Home » Piramal Buys Bayer’s Imaging Portfolio
Piramal Buys Bayer’s Imaging Portfolio
In a deal that could propel the $650-million Piramal Healthcare into the billion dollar revenue league, the Ajay Piramal-led company has bought the molecular imaging research and development portfolio of Bayer AG, which includes the rights to an Alzheimer’s treatment drug.
Hindustan Times
Hindustan Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May